http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108503689-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 |
| filingDate | 2017-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108503689-B |
| titleOfInvention | Anti-platelet aggregation polypeptide KM6 |
| abstract | An anti-platelet aggregation polypeptide KM 6. The invention belongs to the technical field of medical biology, and particularly relates to a novel polypeptide with a platelet aggregation inhibiting effect. The polypeptide is polypeptide KM6 consisting of 10 amino acids, has the sequence of polypeptide of SEQ ID NO. 1, has the sequence of Gln-Leu-Ser-Asn-Gly-Asn-Arg-Thr-Leu-Thr, and has the molecular weight of 1103.19 Da. The polypeptide has a remarkable inhibiting effect on platelet aggregation induced by collagen, ADP and arachidonic acid, can be used for exploring the influence of the polypeptide and other platelet activators (epinephrine, ristocetin and the like) on the platelet and related functions, and can also be used for monitoring the conventional antiplatelet treatment. |
| priorityDate | 2017-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 115.